Skip Navigation
Grant Details

Grant Number: 5R01CA063682-05 Interpret this number
Primary Investigator: Risch, Harvey
Organization: Yale University
Project Title: Genetic/Epidemiology Study of Epithelial Ovarian Tumors
Fiscal Year: 1998
Back to top


Abstract

An abstract does not currently exist for this grant

Back to top


Publications

ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
Authors: Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, Schildkraut JM, Sutphen R, Tsai YY, Tyrer J, Vierkant RA, Wentzensen N, Yang HP, Terry KL, Tworoger SS
Source: Cancer Causes Control, 2012 Nov;23(11), p. 1805-10.
EPub date: 2012 Sep 8.
PMID: 22961099
Related Citations

Back to top


Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Authors: Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group
Source: Int J Cancer, 2006 May 1;118(9), p. 2281-4.
PMID: 16331614
Related Citations

Back to top


Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
Authors: Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF
Source: J Med Genet, 2005 Jul;42(7), p. 602-3.
PMID: 15994883
Related Citations

Back to top


Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Authors: Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA
Source: J Natl Cancer Inst, 2004 Jul 21;96(14), p. 1094-8.
PMID: 15265971
Related Citations

Back to top


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Authors: Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF
Source: Am J Hum Genet, 2003 May;72(5), p. 1117-30.
EPub date: 2003 Apr 3.
PMID: 12677558
Related Citations

Back to top


Histopathologic features of genetically determined ovarian cancer.
Authors: Shaw PA, McLaughlin JR, Zweemer RP, Narod SA, Risch H, Verheijen RH, Ryan A, Menko FH, Kenemans P, Jacobs IJ
Source: Int J Gynecol Pathol, 2002 Oct;21(4), p. 407-11.
PMID: 12352190
Related Citations

Back to top


Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.
Authors: Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA
Source: Lancet, 1999 Nov 27;354(9193), p. 1846-50.
PMID: 10584720
Related Citations

Back to top


Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
Authors: Narod SA, Risch H, Moslehi R, Dørum A, Neuhausen S, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet JS, Ponder BA
Source: N Engl J Med, 1998 Aug 13;339(7), p. 424-8.
PMID: 9700175
Related Citations

Back to top